AI-generated summary
The authors tested red laser photobiomodulation (660 nm) in rats with a Walker-256 tumor injected into the hind paw, comparing several light doses against nimesulide and untreated controls. They report that the 1 J dose reduced paw edema and pain sensitivity and altered levels of several inflammatory genes. The study was conducted in animals, so its relevance to human cancer pain is not established.
- Who or what was studied
- Rats with Walker Tumor-256 injected into the hind paw, divided into six groups of six rats
- Wavelengths
- 660 nm
- Limits stated in the abstract
- The study was conducted in rats with a small group size, so findings may not apply to human cancer pain.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
- Total energy
- 1 J, 6 J
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.